Diversity Hub

CTRFP is a yearlong pre-doctoral training program open to students in UCSF School of Medicine, School of Nursing, School of Pharmacy and School of Dentistry. The program provides training and mentorship to pre-doctoral students in clinical and translational research methodology and practice. Students who wish to participate must take a year off from their studies and commit one year (July-June) to clinical and translational research work under the guidance of a UCSF mentor. The program is also available to medical students outside of UCSF through the Doris Duke International Clinical Research Fellowship (details can be found here: CTR Fellowship Programs International Research). Funding for this yearlong program is available to students through RAPtr and Doris Duke Charitable Foundation.

Career Development provide resources to enable greater diversity at UCSF, to support mentorship, and to improve the recruitment and retention of under-represented clinical and translational researchers. The goal of this program aims; (1) To advance the careers of clinical and translational researchers by providing career advice, research mentoring, and support; (2) To advance under-represented groups in clinical and translational science at UCSF, in collaboration with the UCSF Chancellor's Diversity Initiative and School-based Diversity Taskforces, the CTSI CD Program has vigorous programs to recruit and retain underrepresented faculty and trainees; and (3) To promote culture change so that clinical and translational researchers are appropriately rewarded.

The Visiting Elective Scholarship Program supported by the UCSF Department of Medicine's Residency Diversity Committee and UCSF CTSI was established to encourage fourth year medical students who are underrepresented in medicine or are interested in working and conducting research with diverse populations to apply for a clinical elective in at UCSF.

The K Scholars program, part of CTSI's Clinical and Translational Science Training (CTST) program, supports the career development of junior faculty building careers in clinical and translational research. This program serves the needs of junior faculty from all four UCSF Schools and from a range of disciplines and backgrounds. Annual enrollment in this popular program now consistently exceeds 50 scholars. View all K Scholars and program faculty on the program's website.

This grant mechanism provides support for senior fellows, instructors, assistant, associate and full professor faculty from historically disenfranchised racial and ethnic groups that are under-represented in health sciences, or from economically disadvantaged backgrounds. The goal is to encourage fellows and faculty from these groups to remain in academia as career professionals and thus to increase the diversity of our faculty. Research can be any area relevant to clinical and translational research which includes bench-to-bedside/laboratory-to-human (T1) translational research, clinical research and bedside-to-community/evidence-to-practice (T2/T3) research. Social, behavioral and economic research as it affects health is included. If not directly involving the study of people or populations, the proposed research must be clearly justified as being on the path to potential use in humans.

During the development of a research career, junior faculty need to focus intensively on their research for a critical period of time. Due to the demands of family care, faculty may struggle to keep up with an ambitious research agenda especially during and immediately after periods of more intense family caregiving. The funding will fill a gap in support for junior faculty with significant family caregiving responsibilities by providing funding for supplemental research support. Eligible faculty conducting clinical or translational research will complete a structured application describing the need for additional support, the value and goals of the research to be pursued, and how the funding will extend the current research program. The proposed research must be clearly justified as being on the path to potential use in humans.